Navigation Links
FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in New York
Date:5/27/2008

FAIRFAX, Va., May 27 /PRNewswire-USNewswire/ -- The Food Allergy & Anaphylaxis Network (FAAN) will hold its 15th annual Food Allergy Conference in Tarrytown, N.Y., on May 31, 2008. Many families struggle with how best to manage food allergies in their lives. Whether attendees have been living with food allergies for years or are dealing with a new diagnosis, this conference will help.

Conference attendees will learn tips and strategies for living better while managing food allergies. Topics will include causes and symptoms of food-allergic reactions, how food allergies should be diagnosed, strategies for avoiding reactions, how and when to use epinephrine, tips for managing food allergies in schools, ways to prepare a child to manage food allergies, and the latest news on food allergy research.

"There is no cure for food allergy today," said Anne Munoz-Furlong, FAAN Founder and CEO. "Until there is a cure, education is the key to avoiding a reaction. This unique conference brings together hundreds of individuals for a full day of the latest information on living with food allergies."

Anyone who has a food allergy or takes care of someone with a food allergy will benefit from attending. In particular, parents, grandparents, and relatives of children with food allergies, as well as health professionals, registered dietitians, caregivers, child care providers, and school staff, will find the sessions informative.

The New York conference will feature Scott H. Sicherer, M.D. He is an associate professor of pediatrics in the Jaffe Food Allergy Institute's division of allergy/immunology at the Mount Sinai School of Medicine, as well as the author of Understanding and Managing Your Child's Food Allergies and The Complete Peanut Allergy Handbook.

There are even special sessions for teens (ages 11 and up) and nurses at the conference. The teen lunch session will include discussion topics such as school, dating, traveling, and dining o
'/>"/>

SOURCE Food Allergy & Anaphylaxis Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Naked Juice Brings Consumers Happiness by the Billions With First 100% Juice Smoothie Containing Probiotics
2. Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina
3. Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During America on the Move Week With the YMCA, September 22-29, 2007
4. PSI Brings its Pioneering Efforts to a Close
5. Serta Brings Sweet Dreams and a Special Delivery to Deserving Women
6. Eclipsys User Network Brings Eclipsys Clients Together to Share Outcome Improvement Strategies
7. Governor Rendell Brings Tour to Insure to Scranton and Urges Passage of Plan to Give Access to Affordable Health Insurance
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. IncentOnes Sue Lewis brings "The Art and Science of Incentive Management" to AHIP Business Forum
10. American Diabetes Month(R) Brings Awareness to Growing Health Care Crisis
11. Maine Natural Health Company Brings Omega-3 Benefits to Pets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire/-SentinelleMedicalInc.,aleadingman...oftwarelaunchesasuiteofnewleadingedgeclinicalappli...matthisyear,sRadiologicalSocietyofNorthAmerica(RSN...00,HallA).Theapplicationsleveragetheuniquehighqual...ingcoilsandsupportmultipleimagingmodalitiesformult...
(Date:11/25/2009)...,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInstit...executiveleadershipfor2010. ,, ThenewBoardMembe...publicpolicy,law,finance,governmenthealthprograms,...comesfromawiderangeofpersonalbackgroundsincludingb...thHIVthemselves,andrepresentingmultipleagegroups. ...
(Date:11/25/2009)...ors of testicular cancer who were treated with cis...ects, including neurological side effects and Rayn...with chemotherapy, according to a new study publis...onal Cancer Institute . , Marianne Brydy, M.D., ...y Hospital, in Bergen, Norway, and colleagues cond...
(Date:11/25/2009)...ease blood pressure? This simple question has bee...ew Stress-related gene Modulates High Blood Pressu...sure? This simple question has been the focus of ... has for the first time established a link between...esponse to stress in mice as well as humans. The s...
(Date:11/25/2009)... Evaluation and treatment clinics to resume...ock (Vocus) November 25, 2009 -- Centegra Health S...nd H1N1 vaccine shots at four Centegra Primary Car... of vaccine has arrived. The clinics are at CPC si...y and will be open as follows: ,   Fro...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ournal Health Psychology, by the American Psycholo...with a short temper or mean disposition tend to h...sted even after asthma and smoking were ruled out ...onary Artery Risk Development in (Young) Adults St...
...and a radiation oncologist at Memorial Sloan-Kette... physician patients see can influence the type of...ed men with localized prostate cancer. It found th...a radiation oncologist and an urologist, usually r...
... of Clinical Oncology today, the results of a larg...undwork for decisions that included when or if a ... In patients with metastatic colorectal ca...s necessary. Few studies have examined the...
..., even if it is all subtle, as in Canada apparentl...ard to pin down is more dangerous to mental health...of 180 Korean immigrants living in Canada. ...d author Samuel Noh, professor of psychiatry at th...
...ase, a pair of young US researchers say. The more ...marriage . And never mind the quality of marital l...m Adrianne Frech, a sociology graduate student at ...for depression once in either 1987 or 1988 and the...
...ganizations (AAPPO) is launching a new initiative ...re to those patients diagnosed with diabetes as w...isease. An industry leader, AAPPO today kicked off...iabetes by providing tools and information to the ...
Other Medicine News:Health News:Unhealthy Lungs Linked to Hostility? 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 3Health News:Change in Course of Treatment: Exploring Better Ways 2Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Marriage Could Lift One Out of Depression, New Study 2Health News:AAPPO Launches ACT on Diabetes Initiative to Promote Improved Diabetes Care 2
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...HESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInternat...pendentAmericanproviderofWestern,healthcareproduct...ouncedthattheCompanywillattendthe21stAnnualPiperJa...mber1-2,2009,atthe,NewYorkPalaceHotel. , Mana...esday,December1,2009,andholdone-on-onemeetingsthr...
(Date:11/24/2009)...INE,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix...reatmentsforaorticdisorders,announcedtodaythatitha...thepatentinfringementlawsuitbroughtagainstitinOcto...esDistrictCourtinIndianapolis,Indiana. ,, Endol...nitedStatesPatentandTrademarkOffice(USPTO)conducts...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2The Leapfrog Group Announces New Board Chair 50087 1The Leapfrog Group Announces New Board Chair 50087 2The Leapfrog Group Announces New Board Chair 50087 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 1Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 2Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 4Supply of Key Childrens Vaccine Almost Back to Normal 50081 1Supply of Key Childrens Vaccine Almost Back to Normal 50081 2Supply of Key Childrens Vaccine Almost Back to Normal 50081 3
...NESS WIRE)--May 17, 2007 - Results,published this ...er,vaccine, GARDASIL (Quadrivalent Human Papilloma...as 100 percent effective in,preventing high-grade ...16 and 18, two types strongly associated with thes...d in women who were not,infected with HPV types ta...
...th International Symposium on,Myelodysplastic Synd...ew updated results,from a pivotal Phase II trial e...lood cancer known as myelodysplastic syndromes (MD... H. Lee Moffitt,Cancer Center & Research Insti...rrently taking place in Florence, Italy.,Breakthro...
Other Medicine Technology:Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3
...higher risk diabetic patient, the PneumaticWalker ...iabetics. Similar to the PneumaticWalker, the Pneu...ve dual density insole to eliminate pressure point...shell and full aircell coverage, also helps regula...
...ce is designed for the treatment of diaphyseal fra...rovides post operative support following intra m...al fixation. The brace allows for movement of join...ascularity and encouraging bone growth. For a more...
...tem for the treatment of injuries of the lower leg...forms to the patient's anatomy and in conjunction ...ilization. As the general time of fracture or rupt...es of treatment can be altered significantly. Exce...
...nefits of controlled compression to minimize hemar...he cuff is anatomically designed to completely fit...o/Cuffs can be ordered as a single cuff, or with a...disk). The Cooler is available separately and can ...
Medicine Products: